Pharmaceutically acceptable salt of the compound2-(2-amino-1, 6-dihydro-6 oxo-purin-9-yl) methoxy-3-hydro-1propanyl-l-valinate

PK140864AUndetermined Publication Date: 2010-08-11F HOFFMANN LA ROCHE & CO AG
0 Cites 0 Cited by

Patent Information

Application Number
PK200800494
Authority / Receiving Office
PK · PK
Patent Type
Applications
Current Assignee / Owner
Publication Date
2010-08-11
Patent Text Reader

Abstract

The L-monovaline ester derived from 2 (2-amino-1,6-5 dihydro-6-oxo-purin-9 yl)methoxy-1,3-propanediol and its pharmaceutically acceptable salt are disclosed which are of value as antiviral agents with improved absorption.
Need to check novelty before this filing date? Find Prior Art